A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL)

NCT04954326 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Lyophilized S95014
DRUG: Liquid S95014

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]
[object Object]